Nashville Soccer Club Unveils New Man in Black Kit Honoring the Life & Legacy of Johnny Cash
17.2.2023 15:00:00 EET | Business Wire | Press release
Nashville Soccer Club unveiled today their brand-new Man in Black Kit, honoring one of the most influential singer-songwriters of all time, Johnny Cash. Watch the launch video here.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230217005049/en/
Photo ID (left to right): John Carter Cash & Hany Mukhtar Photo: Courtesy of Nashville SC
Created in collaboration with the estate of Johnny Cash, Sandbox Succession, and Wasserman Music, the Man in Black Kit was inspired by The Backline Supporters Collective, the club’s fans. On Feb. 29, 2020, Nashville SC inaugurated its journey in Major League Soccer in front of 59,069 fans, a state record for a soccer match. Prior to kickoff, The Backline unveiled their first ever MLS TIFO, featuring the Man in Black alongside the Nashville SC logo. Inspired by that moment, Nashville SC and The estate of Johnny Cash began collaborating to tell the story of the life and legacy of Cash.
The all-black ensemble is embellished by dark graphite and iron metallic accents including a jocktag of Johnny Cash’s iconic photo at Folsom Prison, Cash’s autograph on the back-of-the-neck, the Nashville SC crest, and an iron metallic Renasant Bank logo as well as an adidas logo. The left sleeve celebrates the Apple and MLS partnership by featuring the Apple TV and MLS logos, and the right sleeve features the Hyundai logo.
“From the first day we started Nashville Soccer Club, we talked a lot about being ‘uniquely Nashville,’” said Nashville SC CEO Ian Ayre. “This city is steeped in music history and Icons of that industry. None more so than the Man in Black himself, Johnny Cash. From our opening match on Feb. 29th, 2020 when our supporters, The Backline, unveiled a Tifo with that famous Johnny Cash image, there has clearly been a strong connection between both The Cash Family and the NSC family. I don’t think there can be a greater tribute to Johnny’s place in music history or Nashville than to have a team full of Men in Black take the field on behalf of Nashville SC.”
“Nashville meant so much to my father, both as a historical music community and a welcoming home,” says John Carter Cash . “Connecting the Cash legacy to Nashville Soccer Club and Major League Soccer, and the joy it’s bringing to Nashville residents, would have made him proud. I’m delighted to see the Man in Black celebrated alongside the Boys in Gold.”
Tomorrow, Saturday, Feb. 18, Nashville fans have the opportunity to see and purchase the Man in Black Kit at a public event at the Walk of Fame Park (across from the Country Music Hall of Fame). The festival-like celebration will kick-off at 11:30 a.m. CT with a DJ, player appearances, photo ops and much more. Other activations include a hospitality area and Heineken® Silver Beer Garden where fans can purchase $4 Heineken® products as well as get a first taste of the new Heineken® Silver, Nashville SC player autograph tent, a stage photo opportunity, Fanatics servicing and order pickup, and Tempo the Coyote’s Band Kids Club registration, among others.
Nashville SC will don the Man in Black Kit for the very first time on Saturday, Feb. 25 as it hosts New York City FC as the first match of the MLS Is Back weekend. Scheduled to kick off at 3:30 p.m. CT, the match will honor the collaboration with a special ‘Man In Black’ match. Limited tickets remain available at www.NashvilleSC.com/Tickets.
Fans around the world can witness the kit debut for free on MLS Season Pass, the new, unprecedented streaming service available on the Apple TV app that will feature every MLS match live, with no blackouts. The match will also broadcast on FOX and Fox Deportes.
To celebrate the launch of the Nashville SC Man in Black Kit, now featured on the official Nashville SC Apple Music playlist, fans can enjoy an exclusive pair of Johnny Cash singles: “God’s Gonna Cut You Down,” a rendition performed by breakout country artist Bailey Zimmerman; and a take on the classic “Man in Black” by Música Mexicana singer Carín León. Additionally, Nashville SC has created a dedicated Apple Maps Guide to everything fans need to know about Nashville SC Match Day, from prematch tailgates to in-stadium eats.
Following its debut, the Man in Black Kit will be featured throughout the 2023 and 2024 MLS seasons, and is available for fans to purchase here. In addition to the kit, the partnership will include special collaborations, which will be offered exclusively through Fanatics, the clubs official retail partner, throughout the two seasons.
MEDIA RESOURCES: Photos, video and b-roll
http://www.nashvillesc.com/maninblack
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230217005049/en/
Contact information
Zach Hunt
615-321-3110
zach@tsgnashville.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Galderma Receives U.S. FDA Approval for Differin ® Epiduo ® Acne Gel Prescription-to-OTC Switch22.5.2026 19:25:00 EEST | Press release
Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) use in ages 12 years and older, marking a significant Prescription-to-OTC transition in acne care. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522074280/en/ The U.S. FDA approves Differin® Epiduo® Acne Gel Prescription-to-OTC switch This milestone represents yet another example of Galderma’s unique Integrated Dermatology strategy, demonstrating how proven innovations from its Therapeutic Dermatology portfolio can further strengthen its Dermatological Skincare offerings. The Prescription‑to‑OTC transition highlights Galderma’s scale and expertise in successfully commercializing dermatology innovations across the full spectrum of acne care. With the appro
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 17:18:00 EEST | Press release
Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522186975/en/ Adam Plich, CEO and Co-Founder of Avanzanite Bioscience. “Thalassaemia is a complex, chronic and multisystem disease characterised by anaemia, ineffective erythropoiesis and haemo
ICE Brent and ICE WTI Perpetual Futures to Launch on OKX22.5.2026 15:30:00 EEST | Press release
OKX, a blockchain technology and trading company serving more than 120 million customers globally,and Intercontinental Exchange (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets including the New York Stock Exchange, today announced plans for OKX to launch perpetual futures based on ICE's Brent Crude and WTI Crude energy benchmarks. The products are expected to be available to trade on OKX’s platform in jurisdictions where OKX is licensed to offer perpetual futures products. The new OKX contracts represent a major step forward in expanding regulated access to global commodity markets through digital asset infrastructure. This first product collaboration between OKX and ICE comes after the companies established a strategic relationship in March 2026. ICE operates some of the world’s leading exchanges, clearing houses and market data services across energy, commodities, fixed income and equities markets. ICE’s future
Enhertu ® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors22.5.2026 15:00:00 EEST | Press release
Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from patients with HER2 positive (IHC 3+) tumors in three phase 2 trials including DESTINY-PanTumor02,DESTINY-Lung01 andDESTINY-CRC02 where Enhertu demonstrated clinically meaningful responses across a broad range of tumors. The recommendation will now be reviewed by the European Commission, which has the authority
Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly22.5.2026 14:45:00 EEST | Press release
Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning solutions address critical challenges in early detection, continuous population insight and more timely decision making, signalling a shift in health systems from late-stage treatment to earlier intervention. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522587414/en/ Selected from 393 submissions across 68 countries, the winning teams were recognised through the inaugural ‘Future Health Challenge 2026: Building Anticipatory Health Systems through Population Sensing’, delivered by Future Health – A Global Initiative by Abu Dhabi in collaboration with MIT Solve. Health systems globally are facing rising costs and persistent delays in diagnosis, with many conditions still identified only after symptoms become severe. At the sam
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom